Cosmos is a vertically integrated healthcare group with a portfolio that spans pharmaceutical and nutraceutical brands, pharmaceutical distribution, proprietary and contract manufacturing as well as an emerging set of technology- and services-oriented assets. COSM is a rare opportunity for investors as a company that has solid revenue and expanding its core, while also growing its pharmaceutical business using advanced AI technology.